Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. [electronic resource]
Producer: 20080520Description: 564-7 p. digitalISSN:- 0275-004X
- Acute Disease
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Anti-Bacterial Agents -- therapeutic use
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Choroidal Neovascularization -- drug therapy
- Drug Therapy, Combination
- Endophthalmitis -- drug therapy
- Eye Infections, Bacterial -- drug therapy
- Female
- Humans
- Incidence
- Injections -- adverse effects
- Macular Degeneration -- drug therapy
- Risk Factors
- Staphylococcal Infections -- drug therapy
- Staphylococcus -- isolation & purification
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity
- Vitreous Body -- microbiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.